McCamish Mark Anthony

McCamish Mark Anthony's trades of Avadel Pharmaceuticals PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-29 2023-12-28
PS Planned sale
75,000 -52.8%
14.53
USD 1,089,750 		75,000 -52.8% 14.53 USD 1,089,750
2023-08-15 2023-08-11
S Sale
28,975 -16.9%
14.93
USD 432,614 		28,975 -16.9% 14.93 USD 432,614
2020-09-18 2020-09-17
B Purchase
52,398 +44.2%
5.83
USD 305,250 		52,398 +44.2% 5.83 USD 305,250
2020-09-18 2020-09-16
B Purchase
118,602 +inf%
5.73
USD 679,969 		118,602 +inf% 5.73 USD 679,969
2020-04-03 2020-04-01
S Sale
30,237 -86.8%
95.42
USD 2,885,236 		30,237 -86.8% 95.42 USD 2,885,236
2020-04-03 2020-04-01
S Sale
2,340 -6.3%
95.41
USD 223,268 		2,340 -6.3% 95.41 USD 223,268
2019-06-27 2019-06-25
PS Planned sale
8,199 -11.9%
11.02
USD 90,391 		8,199 -11.9% 11.02 USD 90,391
2019-06-24 2019-06-20
PS Planned sale
8,301 -12.0%
11.04
USD 91,626 		8,301 -12.0% 11.04 USD 91,626
2019-05-22 2019-05-20
PS Planned sale
1,291 -2.1%
12.46
USD 16,080 		1,291 -2.1% 12.46 USD 16,080
2019-05-22 2019-05-20
PS Planned sale
15,209 -20.0%
12.07
USD 183,646 		15,209 -20.0% 12.07 USD 183,646
2019-04-22 2019-04-18
PS Planned sale
16,500 -21.4%
18.12
USD 299,054 		16,500 -21.4% 18.12 USD 299,054
2019-03-21 2019-03-19
PS Planned sale
16,500 -21.4%
18.15
USD 299,401 		16,500 -21.4% 18.15 USD 299,401
2019-02-21 2019-02-20
PS Planned sale
9,410 -13.4%
14.94
USD 140,546 		9,410 -13.4% 14.94 USD 140,546
2019-02-21 2019-02-19
PS Planned sale
7,090 -10.5%
15.06
USD 106,797 		7,090 -10.5% 15.06 USD 106,797
2019-01-23 2019-01-18
PS Planned sale
20,000 -68.9%
14.59
USD 291,892 		20,000 -68.9% 14.59 USD 291,892
// ... existing code ... // ... rest of the file ...